Microscope Software Market Worth $1,021 Million By 2025
Seeking Alpha Analyst Since 2014
#Healthcare Consultant focusing on #TeleHealth #TeleMedicine #PatientPortals #CVIS #HCIT #MedicalRobots #Vaccines #MedicalDevices #WirelessHealth #Biotechnology
Summary
- FAVORABLE FUNDING SCENARIO FOR MICROSCOPY R&D.
- TECHNOLOGICAL ADVANCEMENTS IN MICROSCOPY SOFTWARE & MICROSCOPES.
- EMERGING APPLICATIONS OF MICROSCOPY.
Overview of This Study:
This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial analysis of the Global Microscope Software Market.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the microscope software market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.
Recent Developments in this Industry:
# In 2019, Leica Microsystems (A part of Danaher) launched LAS X Steel Expert software for the fast and accurate rating of non-metallic inclusions in steel.
# In 2020, JOEL Ltd had an agreement with DI Corporation (South Korea) to acquire all of the DI-owned shares of JEOL Korea Ltd. and make JK a wholly-owned subsidiary of JEOL.
# In 2019, Carl Zeiss AG launched the ZEISS ZEN core software suite that offers new analysis and connectivity modules.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89006739
What the Market Looks Like?
The global microscope software market size is projected to reach USD 1,021 million by 2025 from USD 567 million in 2020, at a CAGR of 12.5% between 2020 and 2025.
Asia Pacific (APAC) is the largest regional market for microscope software in 2019
Asia Pacific (comprising Japan, China, India, and the Rest of Asia Pacific) accounted for the largest share of the global market, followed by North America. Factors such as the significant R&D budgets, wide availability of advanced microscopy software offered by market leaders, growing focus on nanotechnology, and the presence of a large number of major research institutes and universities in the region are driving the growth of the microscope software market in the Asia Pacific.
Emerging markets such as China, India, Brazil, and countries in the Middle East are expected to offer significant growth opportunities for market players in the coming years, primarily due to the rising R&D funding for microscopy.
Key Players:
Prominent players in the microscope software market are Danaher Corporation (US), Carl Zeiss AG (Germany), Oxford Instruments plc (UK), Nikon Corporation (Japan), Olympus Corporation (Japan), Thermo Fisher Scientific (US), Hitachi High-Tech Corporation (Japan), JEOL Ltd. (Japan), Scientific Volume Imaging B.V. (Netherlands), arivis AG (Germany), DRVISION Technologies (US), Media Cybernetics, Inc. (US), Gatan, Inc. (US), Basler AG (Germany), Nanolive SA (Switzerland), Nion Company (US), and Object Research Systems, Inc. (Canada).
Players in this market focused on partnerships, collaborations, agreements, acquisitions, mergers, expansions, and product launches & upgrades to expand their market presence between January 2017 and July 2020.
Connect With Our Research Experts for More Detailed Information@
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=89006739
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.